Le Lézard
Classified in: Science and technology
Subject: IPO

Marqeta Announces Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares


Marqeta, Inc. (NASDAQ: MQ) today announced that the underwriters of its initial public offering have exercised in full their option to purchase from Marqeta an additional 6,818,181 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The sale of these additional shares of Class A common stock closed earlier today, following the closing on June 11, 2021 of the sale of 45,454,546 shares of Marqeta's Class A common stock. As a result, Marqeta has received total gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $1.41 billion.

Goldman Sachs & Co. LLC and J.P. Morgan acted as lead book-running managers for the offering. Citigroup, Barclays, William Blair and KeyBanc Capital Markets acted as book-running managers. Nomura, HSBC, R. Seelaus & Co., LLC and Siebert Williams Shank acted as co-managers.

The offering was made only by means of a prospectus. Copies of the prospectus may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526; and J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866-803-9204 or email at [email protected].

A registration statement relating to the offering has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Marqeta

Marqeta's modern card issuing platform empowers its customers to create customized and innovative payment cards. Marqeta's modern architecture gives its customers the ability to build more configurable and flexible payment experiences, accelerating time-to-market and democratizing access to card issuing technology. Marqeta's open APIs provide instant access to highly scalable, cloud-based payment infrastructure that enables customers to launch and manage their own card programs, issue cards and authorize and settle payment transactions. Marqeta is headquartered in Oakland, California and is certified to operate in 36 countries globally.


These press releases may also interest you

at 09:10
Mosyle, the only Apple Unified Platform, today announced the launch of Mosyle Fuse MSP, the first solution that integrates five critical management and security applications into a single, Apple-only product specifically designed for Managed Service...

at 09:10
FundingShield is pleased to announce that John Hedlund has joined its advisory board. John Hedlund, founder of Adanac Advisory Group (AAG), a boutique advisory and consulting firm, recently retired from AmeriHome Mortgage, a Western Alliance Bank...

at 09:10
Siri's first Head of Product and Design, Mads Rydahl, has funneled his extensive knowledge of AI and Large Language Models (LLMs) into a new company; Proemial. The startup, co-founded by serial entrepreneur Geet Khosla and tech veteran Brian...

at 09:10
Orca Security, the leader in agentless cloud security, today announced significant new capabilities and services that enable rapid investigation and response to cloud-native infrastructure attacks. With the general availability of cloud digital...

at 09:06
Daqo New Energy Corp. ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31,...

at 09:05
GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support...



News published on and distributed by: